AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

13,592.00p
   
  • Change Today:
      78.00p
  • 52 Week High: 14,148.00
  • 52 Week Low: 9,667.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.73m
  • Volume: 1,461,235
  • Market Cap: £210,775m
  • RiskGrade: 123

Latest ShareCast News

AstraZeneca secures US approval for Imfinzi in gastric cancer

By Iain Gilbert

Date: Wednesday 26 Nov 2025

(Sharecast News) - Drugmaker AstraZeneca said on Wednesday that its Imfinzi asset has been approved in the US for use alongside standard FLOT chemotherapy in the treatment of adult patients with resectable, early‑stage and locally advanced gastric and gastroesophageal junction cancers.

AstraZeneca ShareCast News

AstraZeneca to spend $2bn in US manufacturing push 24-Nov-2025 ShareCast
AstraZeneca receives FDA approval for expanded K... 20-Nov-2025 ShareCast
Director dealings: 3i execs buy the dip, AstraZe... 14-Nov-2025 ShareCast
AstraZeneca beats Q3 expectations, maintains FY ... 06-Nov-2025 ShareCast
AstraZeneca's Koselugo receives EU approval 28-Oct-2025 ShareCast

AstraZeneca Regulatory News

Holding(s) in Company 04-Dec-2025 15:00 RNS
Block listing Interim Review 01-Dec-2025 15:05 RNS
Total Voting Rights 01-Dec-2025 15:00 RNS
Imfinzi approved in US for early gastric cancer 26-Nov-2025 07:00 RNS
AstraZeneca manufacturing investment in Maryland 24-Nov-2025 07:00 RNS

AstraZeneca Newspaper Links

Fighting Frenchman shows us how as he ensures As... 30-Dec-2014 Daily Mail
Exclusive: UK firms vie for share of £170bn in A... 08-Dec-2014 The Independent
MARKET REPORT: Ariad on the up amid growing spec... 04-Dec-2014 Daily Mail
Some reasons why Pfizer won’t bid for AstraZenec... 19-Nov-2014 Guardian
Pfizer unlikely to try AstraZeneca takeover agai... 07-Nov-2014 Guardian

AstraZeneca Tips & Analysis

Questor :AstraZeneca 29-Apr-2014 Telegraph
Questor : AstraZeneca 24-Jan-2014 Telegraph
Questor:AstraZeneca 22-Dec-2011 Telegraph
Investment Column:AstraZeneca 28-Oct-2011 The Independent
Investment Column: AstraZeneca 23-Jun-2011 The Independent

AstraZeneca News Wires

MedImmune Announces Zook as President 13-Nov-2008 PR Newswire
Survey Shows Lung Cancer Patients Blamed for The... 12-Nov-2008 PR Newswire
CRESTOR Demonstrates Dramatic CV Risk Reduction ... 09-Nov-2008 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 13,592.00p
Change Today 78.00p
% Change 0.58 %
52 Week High 14,148.00
52 Week Low 9,667.00
Volume 1,461,235
Shares Issued 1,550.73m
Market Cap £210,775m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average
90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average
Price Trend
9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Income
68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 13
Neutral 3
Sell 0
Strong Sell 1
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 07-Aug-25 20-Feb-25
Paid 08-Sep-25 24-Mar-25
Amount 103.00¢ 210.00¢

Trades for 05-Dec-2025

Time Volume / Share Price
16:27 0 @ 13,578.00p
16:11 0 @ 13,552.00p
16:11 0 @ 13,552.00p
16:09 0 @ 13,554.00p
16:09 0 @ 13,554.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page